Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist
U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B depressed 5-HT and DA cell firing rates and depressed synthesis of both neurotransmitters. The drug depressed mouse body temperatures by an amou...
Saved in:
Published in | The Journal of pharmacology and experimental therapeutics Vol. 268; no. 3; pp. 1304 - 1310 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
American Society for Pharmacology and Experimental Therapeutics
01.03.1994
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine
(DA) receptor sites. U-67413B depressed 5-HT and DA cell firing rates and depressed synthesis of both neurotransmitters. The
drug depressed mouse body temperatures by an amount similar to that for buspirone, gepirone and ipsapirone, but less than
that for 8-hydroxy-N,N-dipropyl-2-aminotetralin. In rats, it produced the 5-HT1A behavioral syndrome. In contrast to 5-HT1A
agonists having DA antagonist effects, U-67413B mildly depressed rather than stimulated firing rates of noradrenaline (NA)
neurons in the locus ceruleus by a non-alpha-2 receptor mechanism. In behavioral tests designed to measure anxiolytic activities,
U-67413B was a slightly more effective anxiolytic than standard 5-HT1A anxiolytics (buspirone, gepirone and ipsapirone). The
data are consistent with the hypothesis that effects of 5-HT1A agonists on NA neuron activity are mediated through effects
on dopaminergic mechanisms, and that effects on NA neurons could modulate anxiolytic activities of 5-HT1A agonists. |
---|---|
AbstractList | U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B depressed 5-HT and DA cell firing rates and depressed synthesis of both neurotransmitters. The drug depressed mouse body temperatures by an amount similar to that for buspirone, gepirone and ipsapirone, but less than that for 8-hydroxy-N,N-dipropyl-2-aminotetralin. In rats, it produced the 5-HT1A behavioral syndrome. In contrast to 5-HT1A agonists having DA antagonist effects, U-67413B mildly depressed rather than stimulated firing rates of noradrenaline (NA) neurons in the locus ceruleus by a non-alpha-2 receptor mechanism. In behavioral tests designed to measure anxiolytic activities, U-67413B was a slightly more effective anxiolytic than standard 5-HT1A anxiolytics (buspirone, gepirone and ipsapirone). The data are consistent with the hypothesis that effects of 5-HT1A agonists on NA neuron activity are mediated through effects on dopaminergic mechanisms, and that effects on NA neurons could modulate anxiolytic activities of 5-HT1A agonists. U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B depressed 5-HT and DA cell firing rates and depressed synthesis of both neurotransmitters. The drug depressed mouse body temperatures by an amount similar to that for buspirone, gepirone and ipsapirone, but less than that for 8-hydroxy-N,N-dipropyl-2-aminotetralin. In rats, it produced the 5-HT1A behavioral syndrome. In contrast to 5-HT1A agonists having DA antagonist effects, U-67413B mildly depressed rather than stimulated firing rates of noradrenaline (NA) neurons in the locus ceruleus by a non-alpha-2 receptor mechanism. In behavioral tests designed to measure anxiolytic activities, U-67413B was a slightly more effective anxiolytic than standard 5-HT1A anxiolytics (buspirone, gepirone and ipsapirone). The data are consistent with the hypothesis that effects of 5-HT1A agonists on NA neuron activity are mediated through effects on dopaminergic mechanisms, and that effects on NA neurons could modulate anxiolytic activities of 5-HT1A agonists. |
Author | J T Lum-Ragan R B McCall P F VonVoigtlander M F Piercey P J Schreur A H Tang R A Lahti S R Franklin W E Hoffmann R A Code |
Author_xml | – sequence: 1 givenname: M. F surname: PIERCEY fullname: PIERCEY, M. F organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 2 givenname: A. H surname: TANG fullname: TANG, A. H organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 3 givenname: M. W surname: SMITH fullname: SMITH, M. W organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 4 givenname: J surname: SZMUSZKOVICZ fullname: SZMUSZKOVICZ, J organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 5 givenname: R. A surname: LAHTI fullname: LAHTI, R. A organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 6 givenname: P. F surname: VONVOIGTLANDER fullname: VONVOIGTLANDER, P. F organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 7 givenname: P. J. K. D surname: SCHREUR fullname: SCHREUR, P. J. K. D organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 8 givenname: R. B surname: MCCALL fullname: MCCALL, R. B organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 9 givenname: J. T surname: LUM-RAGAN fullname: LUM-RAGAN, J. T organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 10 givenname: W. E surname: HOFFMANN fullname: HOFFMANN, W. E organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 11 givenname: S. R surname: FRANKLIN fullname: FRANKLIN, S. R organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States – sequence: 12 givenname: R. A surname: CODE fullname: CODE, R. A organization: Upjohn Co., cent. nervous system res., Kalamazoo MI 49001, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3977126$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/7908053$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkF9LwzAUxYNM5jb9CEIfRJ-KSW6ati_CGP6DgT7oc0iTdI20TU06XL-91RXx6R44v3sP5y7RrHWtOUELklASY4JhhhYYUxpDwpMztAzhA2PCGIc5mqc5znACC3T3WknfSOVqtxsiV0YyauzB6CiJq0F7dxh6P3S9bGxryPpWu-5XRnLnWhv6c3RayjqYi2mu0PvD_dvmKd6-PD5v1tu4IoRBTClIo7AqVUoNA6K5pKDyrOCGEYrLIucaA9UADJu0MIlONDOaZ9m4UwCHFbo-3u28-9yb0IvGBmXqWrbG7YNIOcMMKIzg5QTui8Zo0XnbSD-IqfDoX02-DErWpZetsuEPgzxNCf3Juzlild1VX9Yb0f37k6A8EyAIjJnf-vtt_Q |
CODEN | JPETAB |
ContentType | Journal Article |
Copyright | 1994 INIST-CNRS |
Copyright_xml | – notice: 1994 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1521-0103 |
EndPage | 1310 |
ExternalDocumentID | 7908053 3977126 268_3_1304 |
Genre | Journal Article |
GroupedDBID | - 08R 0R 2WC 3O- 4.4 53G 55 5GY 5RE 8RP AALRV ABFLS ABIVO ABOCM ABSGY ABZEH ACGFS ACNCT ADBIT ADCOW ADKFC AENEX AETEA AFFNX AIKQT ALMA_UNASSIGNED_HOLDINGS CS3 DIK DL DU5 EBS EJD F5P FH7 GJ GX1 H13 HZ INIJC KQ8 L7B LSO O9- OK1 P2P R.V R0Z RHF RHI RPT VH1 W2D WH7 WOQ X X7M ZGI ZXP --- -~X .55 .GJ 0R~ 18M 5VS 8WZ A6W AAJMC AAYOK ABCQX ABJNI ABSQV ACGFO ADBBV ADIYS AERNN AFHIN AFOSN AGFXO AI. BAWUL BTFSW E3Z F9R HZ~ IQODW MJL MVM OHT TR2 UQL W8F YBU YHG YQT CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-h1143-223aec0cfc72e431d6a23c98b6e4120fb96d032d3340e7be5d5d4ed6880cfb363 |
ISSN | 0022-3565 |
IngestDate | Fri Oct 25 10:13:40 EDT 2024 Sat Sep 28 07:32:46 EDT 2024 Thu Sep 12 02:08:28 EDT 2024 Tue Jan 05 21:17:27 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Rat Psychotropic Rodentia Discharge pattern Electrophysiology Serotonin agonist In vitro Biological activity In vivo Vertebrata Mammalia D2 Dopamine receptor Tranquillizer Mouse Animal Dopamine agonist S1A receptor Behavior |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-h1143-223aec0cfc72e431d6a23c98b6e4120fb96d032d3340e7be5d5d4ed6880cfb363 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 7908053 |
PQID | 76404323 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_76404323 pubmed_primary_7908053 pascalfrancis_primary_3977126 highwire_pharmacology_268_3_1304 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 1900 |
PublicationDate | 1994-Mar |
PublicationDateYYYYMMDD | 1994-03-01 |
PublicationDate_xml | – month: 03 year: 1994 text: 1994-Mar |
PublicationDecade | 1990 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States |
PublicationTitle | The Journal of pharmacology and experimental therapeutics |
PublicationTitleAlternate | J Pharmacol Exp Ther |
PublicationYear | 1994 |
Publisher | American Society for Pharmacology and Experimental Therapeutics |
Publisher_xml | – name: American Society for Pharmacology and Experimental Therapeutics |
SSID | ssj0014463 |
Score | 1.4812392 |
Snippet | U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine
(DA) receptor sites. U-67413B... U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B... |
SourceID | proquest pubmed pascalfrancis highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1304 |
SubjectTerms | Animals Behavior, Animal - drug effects Biological and medical sciences Diazepam - pharmacology Dopamine Agents - pharmacology Male Medical sciences Mice Molecular Structure Neurons - drug effects Neurons - metabolism Neuropharmacology Pharmacology. Drug treatments Phenalenes Polycyclic Compounds - pharmacology Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Rats Rats, Sprague-Dawley Receptors, Dopamine D2 - drug effects Serotonin Receptor Agonists - pharmacology |
Title | Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist |
URI | http://jpet.aspetjournals.org/content/268/3/1304.abstract https://www.ncbi.nlm.nih.gov/pubmed/7908053 https://search.proquest.com/docview/76404323 |
Volume | 268 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdpYdCX0XUry7puehh9cd3ZkizbL4Mw2oaxjTykJW9GsqUmsNihdWDZX7M_dSd_KqFjHy_GFtgn7ne-D-nuhNA7KWKmRCTdIKDCZVorF2AOXMVYTEQYg9Ksun1-5eMb9mkWzAaDn1bW0rqUF-mPR-tK_gdVGANcTZXsPyDbfRQG4B7whSsgDNe_wnjS953e1IWOy8V38CADd77JTH5Keb9ZlWIJnqQ_AjIZRMjmwRF3Rd4U_rSeaV8jVnmnK_vTZnF96ygAq2qr88m_OFfOZGHyZLpV-pEzdqaisY1mVwfU0GcxLxedQoZ3bov8tljcld-qOpt-FaJuJ0y3Mjra7SU713SyO9NLe6bT3Zna1QX1-REXqlHKxCx5eNTW2oRHlnhSSweDVWa2cQDMVstKAkD0Iq_uTbzdeXvHInZ5ikAkoWbHj-2hPeqblNHrWZdCZEJp2nWjhzkfoCcNCavdtMm2FQ_ww-n6pJTfhzKVSzM9RE8btPGoFqxnaKDyI3TW8HNzjm3eneMzbHP6OfpgP-JCY4Er6cOPSt_7VvZwI3sv0M3V5fTj2G1O43DnEDNTF_xIoVIv1WlIFLidGReEpnEkuWI-8bSMeeZRklHKPBVKFWRBxlTGwUCkWlJOj9F-XuTqJcI0VLHmmpheTUz7UkTC5wQcad-LBBF0iHDLvcQW96THY4hOt7iarOrmLIkJaHzCh-hty-UEFKbZBRO5KtYPSchNQykCRI5r5nevNti9-jP1E3TQ_wSv0X55v1an4JyW8k0lIb8ABY2YGg |
link.rule.ids | 315,782,786 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacology+of+a+mixed+5-hydroxytryptamine1A%2Fdopamine+agonist&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=M+F+Piercey&rft.au=A+H+Tang&rft.au=R+A+Lahti&rft.au=P+F+VonVoigtlander&rft.date=1994-03-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=268&rft.issue=3&rft.spage=1304&rft_id=info%3Apmid%2F7908053&rft.externalDBID=n%2Fa&rft.externalDocID=268_3_1304 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon |